Drug Type Peptide drug conjugates |
Synonyms BGC-0228, BGC0228 |
Target |
Action inhibitors |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | China | 15 Apr 2022 | |
Breast Cancer | Phase 1 | China | 15 Apr 2022 | |
Colorectal Cancer | Phase 1 | China | 15 Apr 2022 | |
Metastatic Esophageal Carcinoma | Phase 1 | China | 15 Apr 2022 | |
Ovarian Epithelial Carcinoma | Phase 1 | China | 15 Apr 2022 | |
Pancreatic Cancer | Phase 1 | China | 15 Apr 2022 | |
Stomach Cancer | Phase 1 | China | 15 Apr 2022 |